ALINITY C ASO
EL ENSAYO ALINITY C ASO SE UTILIZA PARA LA DETERMINACIÓN CUANTITATIVA DE ANTIESTREPTOLISINA O EN SUERO HUMANO EN EL ANALIZADOR ALINITY C. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES.
THE ALINITY C ASO ASSAY IS USED FOR THE QUANTITATIVE DETERMINATION OF ANTISTREPTOLYSIN OR HUMAN SERUM IN THE ALINITY C ANALYZER. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE ANTIESTREPTOLISINA O
- Trade Name (English)
- ASSAY FOR THE DETERMINATION OF ANTISTREPTOLYSIN OR
- Analysis ID
- 2284R2019 SSA
- Registration Date
- December 13, 2019
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ALINITY C ASO (ALINITY C ASO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2284R2019 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 13, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.